Next Generation Cancer Diagnostics Market Overview, Value Chain Analysis and Regional Landscape, 2024
Global next generation cancer diagnostics market size was worth USD 4,964.05 million in 2016 which is anticipated to grow at a CAGR of more than 9.7% over the forecast period.
(firmenpresse) - The global Next Generation Cancer Diagnostics Market research report provides complete insights on industry scope, global trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready, data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.
Market Overview:
Global next generation cancer diagnostics market size was worth USD 4,964.05 million in 2016 which is anticipated to grow at a CAGR of more than 9.7% over the forecast period. Rise in mortality rate due to the increasing occurrence of the cancer, second most predominant disease accounting for approximately 8.8 million deaths in 2015 is anticipated to escalate the market for these tests.
Key Players:
Janssen Global Services, LLC
Novartis AG
Hoffmann-La Roche Ltd
Koninklijke Philips N.V.
Abbott
Request free sample to get a complete analysis of top-performing companies (at) https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics-market/request-sample
Growth Drivers:
Advancements in tests enable early diagnosis and assist efficient detection of different types of tumors which in turn is expected to promote growth over the projected period. The introduction of new products by large bodies, merger, and acquisitions, and joint agreements such as the development of RNA-Seq Kit version by Agilent Technologies Inc. and Agendia Inc. are the factors accountable for the estimated CAGR.
An escalation in the development of companion diagnostics in order to deliver advanced and personalized genomic medicine is also responsible for progress in the coming years.
Application Outlook:
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
Technology Outlook:
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays
Regional Insights:
The next generation cancer diagnostics market is dominated by North America with approximately 40% market share. Favorable government initiatives such as launch of “80% by 2018” program for detection of colon cancer is anticipated to propel progress in the coming years.
Asia Pacific is anticipated to be the fastest developing region. Factors such as economic augmentation, higher investments, and greater untapped market are accountable for the fastest growth of resign in diagnosis sector.
Browse Related Category Research Reports (at) https://blog.naver.com/tomclark
Themen in dieser Pressemitteilung:
healthcare
next-generation-cancer-diagnostics-market
next-generation-cancer-diagnostics-market-news
global-next-generation-cancer-diagnostics-industry-size
next-generation-cancer-diagnostics-market-share
next-generation-cancer-diagnostics-market
Unternehmensinformation / Kurzprofil:
Datum: 25.09.2020 - 12:47 Uhr
Sprache: Deutsch
News-ID 620073
Anzahl Zeichen: 3085
contact information:
Contact person: Tom Clark
Town:
Felton
Phone: 4086102300
Kategorie:
Healthcare
Typ of Press Release: Financial
type of sending: don't
Date of sending: 25.09.2020
Diese Pressemitteilung wurde bisher 372 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Next Generation Cancer Diagnostics Market Overview, Value Chain Analysis and Regional Landscape, 2024"
steht unter der journalistisch-redaktionellen Verantwortung von
Million Insights (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
